Table 2.
Drug resistance | DR-TB patients without diabetes n=1153/6797 (16.96%) | DR-TB patients with diabetes n=93/426 (21.83%) | P-value |
---|---|---|---|
DR-TB (total) | 1153 (16.96) | 93 (21.83) | 0.01* |
Any resistance to first-line drug | |||
INH | 659 (9.70) | 52 (12.21) | 0.09 |
RFP | 298 (4.38) | 25 (5.87) | 0.15 |
EMB | 91 (1.34) | 7 (1.64) | 0.60 |
SM | 795 (11.70) | 69 (16.20) | 0.005** |
MR TB (total) | 678 (9.97) | 50 (11.74) | 0.24 |
INH | 216 (3.18) | 13 (3.05) | 0.89 |
RFP | 58 (0.85) | 4 (0.94) | 0.78 |
EMB | 13 (0.19) | 0 (0.00) | 1.00 |
SM | 386 (5.68) | 33 (7.75) | 0.08 |
Others | 5 (0.07) | 0 (0.00) | 1.00 |
MDR (total) | 213 (3.13) | 17 (4.00) | 0.33 |
MDR1:INH+RFP | 46 (0.68 | 6 (1.41) | 0.08 |
MDR2:INH+RFP+EMB+SM | 45 (0.66) | 6 (1.41) | 0.07 |
MDR3:INH+RFP+SM | 110 (1.62) | 5 (1.17) | 0.48 |
Others | 12 (0.18) | 0 (0.00) | 1.00 |
PDR | 258 (3.80) | 26 (6.10) | 0.02* |
PDR1:INH+EMB | 7 (0.10) | 1 (0.23) | 0.39 |
PDR2:INH+SM | 213 (3.13) | 21 (4.93) | 0.04* |
PDR3:RFP+SM | 20 (0.29) | 4 (0.94) | 0.05 |
Others | 18 (0.26) | 0 (0.00) | 0.62 |
Note: *P<0.05; **P<0.01.
Abbreviations: TB, tuberculosis; DR-TB, drug-resistant tuberculosis; MR-TB, monoresistant tuberculosis; MDR-TB, multiresistant tuberculosis; PDR-TB, polydrug resistant tuberculosis; EMB, ethambutol; INH, isoniazid; RFP, rifampin; SM, streptomycin.